AbbVie Inc.
AbbVie Inc. lists 95 drug products in the FDA National Drug Code directory.
Products
| NDC | Product | Strength | Type |
|---|---|---|---|
| 0032-0046 | Creon Capsule, Delayed Release Pellets | Pancrelipase Amylase 30000 [USP'U]/1; Pancrelipase Lipase 6000 [USP'U]/1; Pancrelipase… | Rx |
| 0032-0047 | Creon Capsule, Delayed Release Pellets | Pancrelipase Amylase 60000 [USP'U]/1; Pancrelipase Lipase 12000 [USP'U]/1; Pancrelipase… | Rx |
| 0032-1203 | Creon Capsule, Delayed Release | Pancrelipase Amylase 15000 [USP'U]/1; Pancrelipase Lipase 3000 [USP'U]/1; Pancrelipase… | Rx |
| 0032-1206 | Creon Capsule, Delayed Release Pellets | Pancrelipase Amylase 30000 [USP'U]/1; Pancrelipase Lipase 6000 [USP'U]/1; Pancrelipase… | Rx |
| 0032-1212 | Creon Capsule, Delayed Release Pellets | Pancrelipase Amylase 60000 [USP'U]/1; Pancrelipase Lipase 12000 [USP'U]/1; Pancrelipase… | Rx |
| 0032-1224 | Creon Capsule, Delayed Release Pellets | Pancrelipase Lipase 24000 [USP'U]/1; Pancrelipase Protease 76000 [USP'U]/1; Pancrelipase… | Rx |
| 0032-2636 | Creon Capsule, Delayed Release Pellets | Pancrelipase Lipase 24000 [USP'U]/1; Pancrelipase Protease 76000 [USP'U]/1; Pancrelipase… | Rx |
| 0032-2637 | Creon Capsule, Delayed Release Pellets | Pancrelipase Lipase 36000 [USP'U]/1; Pancrelipase Amylase 180000 [USP'U]/1; Pancrelipase… | Rx |
| 0032-3016 | Creon Capsule, Delayed Release Pellets | Pancrelipase Lipase 36000 [USP'U]/1; Pancrelipase Amylase 180000 [USP'U]/1; Pancrelipase… | Rx |
| 0032-0045 | Creon Capsule, Delayed Release | Pancrelipase Amylase 15000 [USP'U]/1; Pancrelipase Lipase 3000 [USP'U]/1; Pancrelipase… | Rx |
| 0074-0282 | Decnupaz Injection, Powder, Lyophilized, For Solution | Pivekimab Sunirine 2 mg/mL | Rx |
| 0074-7325 | Depakote Tablet, Delayed Release | Divalproex Sodium 125 mg/1 | Rx |
| 0074-7327 | Depakote Tablet, Delayed Release | Divalproex Sodium 500 mg/1 | Rx |
| 0074-7326 | Depakote Tablet, Delayed Release | Divalproex Sodium 250 mg/1 | Rx |
| 0074-7401 | Depakote ER Tablet, Extended Release | Divalproex Sodium 250 mg/1 | Rx |
| 0074-7402 | Depakote ER Tablet, Extended Release | Divalproex Sodium 500 mg/1 | Rx |
| 0074-6114 | Depakote Sprinkles Capsule | Divalproex Sodium 125 mg/1 | Rx |
| 0074-3012 | Duopa Suspension | Levodopa 20 mg/mL; Carbidopa Hydrate 4.63 mg/mL | Rx |
| 0074-3878 | Emblaveo Powder, For Solution | Aztreonam 127 mg/mL; Avibactam 42.3 mg/mL | Rx |
| 0074-1055 | Emrelis Injection, Powder, Lyophilized, For Solution | Telisotuzumab Vedotin 100 mg/mL | Rx |
| 0074-1044 | Emrelis Injection, Powder, Lyophilized, For Solution | Telisotuzumab Vedotin 20 mg/mL | Rx |
| 0074-3109 | Gengraf Capsule | Cyclosporine 100 mg/1 | Rx |
| 0074-3108 | Gengraf Capsule | Cyclosporine 25 mg/1 | Rx |
| 0074-0554 | Humira Kit | Rx | |
| 0074-0817 | Humira Kit | Rx | |
| 0074-0243 | Humira Kit | Rx | |
| 0074-0616 | Humira Kit | Rx | |
| 0074-4339 | Humira Kit | Rx | |
| 0074-2540 | Humira Kit | Rx | |
| 0074-1539 | Humira Kit | Rx | |
| 0074-3799 | Humira Kit | Rx | |
| 0074-0124 | Humira Kit | Rx | |
| 0074-3956 | Kaletra Solution | Lopinavir 80 mg/mL; Ritonavir 20 mg/mL | Rx |
| 0074-3008 | Kaletra Tablet, Film Coated | Lopinavir 100 mg/1; Ritonavir 25 mg/1 | Rx |
| 0074-4014 | Kaletra Tablet, Film Coated | Lopinavir 200 mg/1; Ritonavir 50 mg/1 | Rx |
| 0074-3473 | Lupron Depot Kit | Rx | |
| 0074-3641 | Lupron Depot Kit | Rx | |
| 0074-3346 | Lupron Depot Kit | Rx | |
| 0074-3663 | Lupron Depot Kit | Rx | |
| 0074-3683 | Lupron Depot Kit | Rx | |
| 0074-3642 | Lupron Depot Kit | Rx | |
| 0074-3575 | Lupron Depot-PED Kit | Rx | |
| 0074-3779 | Lupron Depot-PED Kit | Rx | |
| 0074-2440 | Lupron Depot-PED Kit | Rx | |
| 0074-2282 | Lupron Depot-PED Kit | Rx | |
| 0074-2108 | Lupron Depot-PED Kit | Rx | |
| 0074-9694 | Lupron Depot-PED Kit | Rx | |
| 0074-2625 | Mavyret Tablet, Film Coated | Pibrentasvir 40 mg/1; Glecaprevir 100 mg/1 | Rx |
| 0074-2600 | Mavyret Pellet | Pibrentasvir 20 mg/1; Glecaprevir 50 mg/1 | Rx |
| 0074-2340 | Norvir Tablet, Film Coated | Ritonavir 100 mg/1 | Rx |
| 0074-3399 | Norvir Powder | Ritonavir 100 mg/1 | Rx |
| 0074-1017 | Oriahnn Kit | Rx | |
| 0074-0039 | Orilissa Tablet, Film Coated | Elagolix Sodium 200 mg/1 | Rx |
| 0074-0038 | Orilissa Tablet, Film Coated | Elagolix Sodium 150 mg/1 | Rx |
| 0074-7094 | Qulipta Tablet | Atogepant 60 mg/1 | Rx |
| 0074-7095 | Qulipta Tablet | Atogepant 10 mg/1 | Rx |
| 0074-7096 | Qulipta Tablet | Atogepant 30 mg/1 | Rx |
| 0074-1043 | Rinvoq Tablet, Extended Release | Upadacitinib 45 mg/1 | Rx |
| 0074-2320 | Rinvoq Solution | Upadacitinib 1 mg/mL | Rx |
| 0074-2310 | Rinvoq Tablet, Extended Release | Upadacitinib 30 mg/1 | Rx |
| 0074-2306 | Rinvoq Tablet, Extended Release | Upadacitinib 15 mg/1 | Rx |
| 0074-1065 | Skyrizi Kit | Rx | |
| 0074-7040 | Skyrizi Kit | Rx | |
| 0074-7042 | Skyrizi Kit | Rx | |
| 0074-5015 | Skyrizi Injection | Risankizumab 600 mg/10mL | Rx |
| 0074-1050 | Skyrizi Injection | Risankizumab 150 mg/mL | Rx |
| 0074-4059 | Skyrizi Injection, Solution | Risankizumab 55 mg/.37mL | Rx |
| 0074-1070 | Skyrizi Kit | Rx | |
| 0074-2100 | Skyrizi Injection | Risankizumab 150 mg/mL | Rx |
| 0074-8350 | Skyrizi Injection | Risankizumab 180 mg/1.2mL | Rx |
| 0074-8300 | Skyrizi Injection | Risankizumab 180 mg/1.2mL | Rx |
| 0074-1040 | Survanta Suspension | Beractant 25 mg/mL | Rx |
| 0074-6594 | Synthroid Tablet | Levothyroxine Sodium 88 ug/1 | Rx |
| 0074-9296 | Synthroid Tablet | Levothyroxine Sodium 112 ug/1 | Rx |
| 0074-3727 | Synthroid Tablet | Levothyroxine Sodium 137 ug/1 | Rx |
| 0074-4341 | Synthroid Tablet | Levothyroxine Sodium 25 ug/1 | Rx |
| 0074-7149 | Synthroid Tablet | Levothyroxine Sodium 300 ug/1 | Rx |
| 0074-7148 | Synthroid Tablet | Levothyroxine Sodium 200 ug/1 | Rx |
| 0074-4552 | Synthroid Tablet | Levothyroxine Sodium 50 ug/1 | Rx |
| 0074-7070 | Synthroid Tablet | Levothyroxine Sodium 175 ug/1 | Rx |
| 0074-7069 | Synthroid Tablet | Levothyroxine Sodium 150 ug/1 | Rx |
| 0074-7068 | Synthroid Tablet | Levothyroxine Sodium 125 ug/1 | Rx |
| 0074-5182 | Synthroid Tablet | Levothyroxine Sodium 75 ug/1 | Rx |
| 0074-6624 | Synthroid Tablet | Levothyroxine Sodium 100 ug/1 | Rx |
| 0074-4456 | Ultane Liquid | Sevoflurane 250 mL/250mL | Rx |
| 0074-0561 | Venclexta Tablet, Film Coated | Venetoclax 10 mg/1 | Rx |
| 0074-0566 | Venclexta Tablet, Film Coated | Venetoclax 50 mg/1 | Rx |
| 0074-0576 | Venclexta Tablet, Film Coated | Venetoclax 100 mg/1 | Rx |
| 0074-0579 | Venclexta Kit | Rx | |
| 0074-7098 | Vuity Solution/ Drops | Pilocarpine Hydrochloride 12.5 mg/mL | Rx |
| 0074-0501 | Vyalev Injection | Foscarbidopa 12 mg/mL; Foslevodopa 240 mg/mL | Rx |
| 0074-4637 | Zemplar Injection, Solution | Paricalcitol 2 ug/mL | Rx |
| 0074-9036 | Zemplar Capsule, Liquid Filled | Paricalcitol 1 ug/1 | Rx |
| 0074-9037 | Zemplar Capsule, Liquid Filled | Paricalcitol 2 ug/1 | Rx |
| 0074-1658 | Zemplar Injection, Solution | Paricalcitol 5 ug/mL | Rx |
Recalls by AbbVie Inc.
- D-0551-2026 Jun 3, 2026 · Class III
Failed Stability Specifications - D-0665-2024 Oct 2, 2024 · Class II
Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal. - D-0664-2024 Oct 2, 2024 · Class II
Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal. - D-0088-2024 Nov 15, 2023 · Class III
Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose. - D-0412-2018 Feb 7, 2018 · Class III
Defective container: presence of a hole in the liners of the caps covering the product bottle, introducing possibility of leakage. - D-0034-2018 Nov 1, 2017 · Class III
Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions. - D-0033-2018 Nov 1, 2017 · Class III
Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions. - D-0495-2017 Mar 8, 2017 · Class II
Failed Stability Specifications: confirmed out of specification results obtained during refrigerated material stability testing indicating that drug may settle within drug cassettes nearing the end… - D-0833-2016 Apr 27, 2016 · Class III
Failed Content Uniformity Specifications - D-901-2013 Aug 28, 2013 · Class III
Labeling: Incorrect Package Insert; product packaged with outdated version of the insert